Intravitreal therapy for Diabetic Macular Oedema (DMO)

Not yet rated

A narrated presenttaion by Mr Kamron Khan, Consultant Ophthalmologist

Intended as pre-learning prior to the interactive session on 6th April 2021 15.00-16.30 via MS Teams

Part of the Eyelearn vitual regional teaching course

On completing this pre-learning, you will :-

1. Understand the current intravitreal treatment options for DMO

2. Review the evidence base for the DMO treatment options

3. Know how to manage DMO patient expectaions with regard to treatment




Additional information

This is a 40 minute review of the evidence that underpins our protocols for the intravitreal treatment of diabetic macular oedema.

Resource details

Community contributions
Contributed to: Community contributions
Community resources are online learning and digital materials provided by the wider Learning Hub community that anyone can contribute to.
Contributed by: Rehna Khan
Authored by: Kamron Khan, Leeds Teaching Hospitals NHS Trust & Calderdale & Huddersfield NHS Trust, Consultant Ophthalmologist
Licence: More information on licences
First contributed: 06 April 2021


0 ratings

Not yet rated
5 star
4 star
3 star
2 star
1 star
Report an issue with this resource

You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.

You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email